[Cost-effectiveness analysis of dapagliflozin compared to DPP4 inhibitors and other oral antidiabetic drugs in the treatment of type-2 diabetes mellitus in Spain].

José Abad Paniagua, Eduardo; Casado Escribano, Pedro; María Fernández Rodriguez, José; J Morales Escobar, Francisco; Betegón Nicolás, Lourdes; Sánchez-Covisa, Joaquín; Brosa, Max

doi:10.1016/j.aprim.2014.11.002

Public

[Cost-effectiveness analysis of dapagliflozin compared to DPP4 inhibitors and other oral antidiabetic drugs in the treatment of type-2 diabetes mellitus in Spain].

Shared by NobleBlocks on Oct 1, 2015 • 12:00 AM UTC

Authors:

Eduardo José Abad Paniagua

Pedro Casado Escribano

José María Fernández Rodriguez

Abstract

OBJECTIVE: To assess the efficiency of the combined therapy with metformin and dapagliflozin, a new oral anti-diabetic drug with an insulin-independent mechanism of action, in the treatment of type-2 diabetes mellitus (T2DM) compared to DPP4 inhibitors, sulphonylureas and thiazolidindiones, also com...

Subject

Costes

Costs

DPP4 inhibitors

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!